IUS Publications

Found 10 results
Filters: Author is Tanja Dujic  [Clear All Filters]
2015
A. Čaušević, Malenica, M., Bego, T., Dujic, T., Prnjavorac, B., Mandal, S., and Semiz, S., THE ASSOCIATION BETWEEN COMMONLY USED INFLAMMATORY MARKERS AND URIC ACID IN PREDIABETES, in Clinical Chemistry and Laboratory Medicine, 53, S1, S605, 2015.
M. Malenica, Bego, T., Dujic, T., Prnjavorac, B., Mandal, S., and Semiz, S., THE ASSOCIATION BETWEEN COMMONLY USED INFLAMMATORY MARKERS AND URIC ACID IN PREDIABETES, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
S. Semiz, Bego, T., Sterner, M., Dujic, T., Velija-Asimi, Z., Prnjavorac, B., Malenica, M., Groop, L., and Čaušević, A., ASSOCIATIONS OF SOLUTE CARRIER TRANSPORTERS GENE VARIATIONS WITH MARKERS OF TYPE 2 DIABETES AND ITS COMPLICATIONS – GENDER SPECIFIC?, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
S. Semiz, Bego, T., Sterner, M., Dujic, T., Velija-Asimi, Z., Prnjavorac, B., Malenica, M., Groop, L., and Čaušević, A., ASSOCIATIONS OF SOLUTE CARRIER TRANSPORTERS GENE VARIATIONS WITH MARKERS OF TYPE 2 DIABETES AND ITS COMPLICATIONS – GENDER SPECIFIC?, in Clinical Chemistry and Laboratory Medicine, 53, S1, S650, 2015.
M. Malenica, Čaušević, A., Silar, M., Dujic, T., Bego, T., Prnjavorac, B., and Semiz, S., DIAGNOSTIC RELEVANCE OF INFLAMMATORY MARKERS IN PREDIABETIC PATIENTS, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
M. Malenica, Čaušević, A., Silar, M., Dujic, T., Bego, T., Prnjavorac, B., and Semiz, S., DIAGNOSTIC RELEVANCE OF INFLAMMATORY MARKERS IN PREDIABETIC PATIENTS, in Clinical Chemistry and Laboratory Medicine, 53, S1, S646, 2015.
T. Dujic, Čaušević, A., Bego, T., Malenica, M., Asimi, Z. Velija-, Pearson, E. R., and Semiz, S., The OCT1 reduced-function polymorphisms are associated with metformin-induced gastrointestinal side-effects,, in Diabetologia 58 (Suppl. 1.), s110, 2015; Presented at European Association for the Study of Diabetes- 51 EASD Annual Meeting, 2015.
Z. Velija- Asimi, Semiz, S., and Dujic, T., Prediabetes incidence and risk of developing cardiovascular disease in women with polycystic ovary syndrome, Endocrine Abstracts, 38, P268. 2015.